DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/8cv4vq/poland_in_vitro_di) has announced the addition of Global Markets Direct's new report "Poland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017" to their offering.

This report provides value (USD million) data for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.

- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the seven market categories.

- Global corporate-level profiles of key companies operating within the Poland In Vitro Diagnostics market.

Key players covered include: F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthcare, Beckman Coulter, Inc., bioMerieux S.A., Ortho-Clinical Diagnostics Inc. and others.

Go here to read the rest:
Research and Markets: Poland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017